Unlocking more answers
in immunodiagnostics

EVALUTION® leverages high quality analytical performance from conventional immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real-time. This provides the user with novel, timely and hence highly actionable information.

In the spotlight

"A MyCartis team is present at Medica, the leading international trade fair for the medical sector in Dusseldorf from 12 till 15 November 2018.
If you want to discuss your topic, let us know on info@mycartis.net"

Making the difference

Evalution® brings significant added value in following domains

Emergency diagnostics

Evalution® runs fast immunoassay panels consisting of biomarkers of highly variable concentration

Patient & therapy monitoring

Evalution® can measure highly variable biomarker panels real-time

More effective immune monitoring

Evalution® is the first solution able to qualify [how strong, how fast] an immune response directly from a clinical sample, on top of the current practice of quantification [how much] and specification [how specific].”

Get inspired on how our technology can be relevant for you

Evalution® platform configurations

to take you from research to commercial applications

See how you can partner with MyCartis

MyCartis offers an open platform approach allowing partners to co-develop assays or port existing assay products on the platform. MyCartis also supports an OEM approach (DMAT® technology inside) in which case MyCartis’ technology is integrated in partner’s existing or new instruments.

Meet our knowledge bank

Join us to unlock more answers